Establishment Labs (ESTA) Financials

$31.45 +1.27 (+4.21%)

Closing price 04/17/2025 04:00 PM Eastern

Extended Trading

$30.00 -1.45 (-4.61%)

As of 04/17/2025 06:18 PM Eastern

Annual Income Statements for Establishment Labs

This table shows Establishment Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-35	-21	-38	-38	-41	-75	-79	-85
Consolidated Net Income / (Loss)	-35	-21	-38	-38	-41	-75	-79	-85
Net Income / (Loss) Continuing Operations	-35	-21	-38	-38	-41	-75	-79	-85
Total Pre-Tax Income	-35	-21	-38	-38	-40	-73	-79	-85
Total Operating Income	-20	-24	-31	-28	-25	-40	-65	-50
Total Gross Profit	18	36	55	53	85	107	107	110
Total Revenue	35	61	90	85	127	162	165	166
Operating Revenue	35	61	90	85	127	162	165	166
Total Cost of Revenue	17	25	35	32	41	55	58	57
Operating Cost of Revenue	17	25	35	32	41	55	58	57
Total Operating Expenses	38	60	86	80	111	146	172	160
Selling, General & Admin Expense	31	47	71	67	92	126	146	140
Research & Development Expense	6.86	13	15	14	18	20	26	20
Total Other Income / (Expense), net	-15	2.98	-6.85	-10	-15	-33	-14	-35
Interest Expense	10	8.81	8.70	9.37	9.06	31	15	21
Interest & Investment Income	0.02	0.02	0.00	0.02	0.02	0.09	1.02	1.48
Other Income / (Expense), net	-4.41	12	1.85	-0.74	-5.53	-2.47	0.82	-15
Income Tax Expense	0.11	0.22	0.64	0.10	1.43	2.39	-0.08	-0.03
Basic Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)
Weighted Average Basic Shares Outstanding	10.23M	17.35M	20.54M	23.32M	23.97M	24.46M	25.60M	28.16M
Diluted Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)
Weighted Average Diluted Shares Outstanding	10.23M	17.35M	20.54M	23.32M	23.97M	24.46M	25.60M	28.16M
Weighted Average Basic & Diluted Shares Outstanding	10.23M	17.35M	20.54M	23.32M	24.12M	24.42M	27.21M	28.85M

This table shows Establishment Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-19	-14	-12	-17	-29	-21	-16	-17	-17	-35
Consolidated Net Income / (Loss)	-19	-14	-12	-17	-29	-21	-16	-17	-17	-35
Net Income / (Loss) Continuing Operations	-19	-14	-12	-17	-29	-21	-16	-17	-17	-35
Total Pre-Tax Income	-18	-13	-11	-16	-29	-23	-16	-17	-16	-36
Total Operating Income	-11	-13	-8.16	-14	-21	-22	-8.83	-9.34	-13	-19
Total Gross Profit	26	28	30	30	26	21	24	29	26	30
Total Revenue	38	44	47	49	39	32	37	44	40	45
Operating Revenue	38	44	47	49	39	32	37	44	40	45
Total Cost of Revenue	12	16	16	18	12	11	13	15	15	14
Operating Cost of Revenue	12	16	16	18	12	11	13	15	15	14
Total Operating Expenses	37	41	38	44	47	43	33	38	39	49
Selling, General & Admin Expense	31	35	32	37	40	37	29	33	34	44
Research & Development Expense	5.29	6.48	6.53	6.95	7.13	5.82	4.27	5.49	4.80	5.14
Total Other Income / (Expense), net	-7.49	0.42	-2.95	-2.11	-7.57	-0.93	-6.93	-7.41	-3.03	-17
Interest Expense	3.88	2.20	3.76	3.62	3.68	4.34	4.38	5.19	5.31	5.95
Interest & Investment Income	0.01	0.03	0.08	0.17	0.27	0.50	0.49	0.56	0.23	0.20
Other Income / (Expense), net	-3.62	2.59	0.73	1.34	-4.16	2.90	-3.04	-2.78	2.05	-12
Income Tax Expense	0.60	0.82	0.83	0.93	0.67	-2.51	0.44	0.43	0.51	-1.41
Basic Earnings per Share	($0.76)	($0.56)	($0.48)	($0.65)	($1.12)	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)
Weighted Average Basic Shares Outstanding	24.51M	24.46M	24.68M	25.62M	26.03M	25.60M	27.79M	27.91M	28.25M	28.16M
Diluted Earnings per Share	($0.76)	($0.56)	($0.48)	($0.65)	($1.12)	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)
Weighted Average Diluted Shares Outstanding	24.51M	24.46M	24.68M	25.62M	26.03M	25.60M	27.79M	27.91M	28.25M	28.16M
Weighted Average Basic & Diluted Shares Outstanding	24.34M	24.42M	25.74M	25.78M	25.81M	27.21M	27.51M	27.94M	28.00M	28.85M

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	10	42	-15	47	-31	13	-26	50
Net Cash From Operating Activities	-32	-34	-30	-13	-28	-52	-89	-59
Net Cash From Continuing Operating Activities	-32	-34	-30	-13	-28	-52	-89	-59
Net Income / (Loss) Continuing Operations	-35	-21	-38	-38	-41	-75	-79	-85
Consolidated Net Income / (Loss)	-35	-21	-38	-38	-41	-75	-79	-85
Depreciation Expense	1.94	2.81	3.29	3.35	3.72	3.87	4.17	6.83
Amortization Expense	7.05	3.32	2.43	2.05	2.48	8.59	14	7.11
Non-Cash Adjustments To Reconcile Net Income	5.83	9.27	10	9.51	14	32	8.97	29
Changes in Operating Assets and Liabilities, net	-12	-28	-7.93	11	-6.76	-22	-37	-17
Net Cash From Investing Activities	-0.85	-5.73	-7.77	-5.56	-7.16	-35	-25	-16
Net Cash From Continuing Investing Activities	-0.85	-5.73	-7.77	-5.56	-7.16	-35	-25	-16
Purchase of Property, Plant & Equipment	-0.90	-1.73	-6.29	-2.42	-5.28	-33	-23	-8.53
Acquisitions	-0.04	-4.00	-1.48	-3.14	-1.88	-2.02	-1.33	-7.08
Net Cash From Financing Activities	43	82	23	65	4.05	100	86	126
Net Cash From Continuing Financing Activities	43	82	23	65	4.05	100	86	126
Repayment of Debt	-16	-5.39	-0.24	-0.28	0.00	-72	0.00	0.00
Issuance of Debt	39	0.00	25	0.00	0.00	168	0.00	24
Issuance of Common Equity	28	88	0.00	64	0.00	0.00	85	99
Other Financing Activities, net	0.00	-0.70	0.54	1.09	4.05	3.87	1.69	1.94
Effect of Exchange Rate Changes	0.21	-0.14	-0.02	0.27	-0.47	-0.36	0.51	-1.46
Cash Interest Paid	2.86	5.38	5.95	6.96	6.93	5.36	5.69	9.81
Cash Income Taxes Paid	0.15	0.14	0.65	0.32	0.65	2.13	2.17	1.74

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-23	-1.69	-24	47	-38	-12	33	-18	-15	51
Net Cash From Operating Activities	-22	-14	-21	-28	-32	-8.15	-11	-14	-12	-21
Net Cash From Continuing Operating Activities	-20	-16	-21	-28	-32	-8.15	-11	-14	-12	-21
Net Income / (Loss) Continuing Operations	-19	-14	-12	-17	-29	-21	-16	-17	-17	-35
Consolidated Net Income / (Loss)	-19	-14	-12	-17	-29	-21	-16	-17	-17	-35
Depreciation Expense	0.98	0.99	0.94	0.95	1.06	1.22	1.27	1.42	1.99	2.15
Amortization Expense	2.84	2.93	3.36	3.50	3.53	3.59	3.59	1.71	0.83	0.99
Non-Cash Adjustments To Reconcile Net Income	7.14	-4.34	0.49	1.52	6.50	0.47	5.76	6.16	2.36	15
Changes in Operating Assets and Liabilities, net	-12	-1.90	-13	-17	-13	7.11	-5.57	-6.26	-0.96	-4.25
Net Cash From Investing Activities	-4.81	-10	-4.28	-9.05	-6.60	-4.62	-6.63	-4.40	-2.77	-1.82
Net Cash From Continuing Investing Activities	-4.81	-10	-4.28	-9.05	-6.60	-4.62	-6.63	-4.40	-2.77	-1.82
Purchase of Property, Plant & Equipment	-4.26	-10	-4.23	-8.97	-6.36	-3.66	-4.75	-1.53	-1.63	-0.62
Acquisitions	-0.55	-0.28	-0.05	-0.08	-0.24	-0.96	-1.88	-2.87	-1.13	-1.20
Net Cash From Financing Activities	1.27	25	1.18	84	0.49	0.07	51	0.39	-0.03	74
Net Cash From Continuing Financing Activities	1.27	25	1.18	84	0.49	0.07	51	0.39	-0.03	74
Issuance of Common Equity	-	-	0.00	85	-	-	50	-	-	50
Other Financing Activities, net	1.27	0.50	1.21	-0.07	0.49	0.07	1.31	0.39	-0.03	0.28
Effect of Exchange Rate Changes	-	-	0.20	0.13	-0.37	0.55	-0.32	-0.21	0.35	-1.27
Cash Interest Paid	1.17	1.18	1.36	1.42	1.42	1.49	1.47	0.03	3.63	4.69
Cash Income Taxes Paid	0.45	0.83	0.22	0.78	0.81	0.36	0.68	0.07	0.07	0.92

This table presents Establishment Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	57	117	117	156	140	211	269	347
Total Current Assets	39	99	96	132	113	150	175	243
Cash & Equivalents	11	53	38	85	53	66	40	90
Accounts Receivable	13	18	23	19	24	35	47	65
Inventories, net	13	25	29	23	28	37	79	79
Prepaid Expenses	2.24	4.30	6.76	5.44	7.01	12	8.48	8.92
Plant, Property, & Equipment, net	14	13	16	16	19	51	77	78
Total Noncurrent Assets	4.21	4.23	4.27	7.89	7.60	10	17	26
Goodwill	0.47	0.47	0.47	0.47	0.47	0.47	0.47	1.21
Intangible Assets	3.40	3.45	3.44	4.15	4.37	4.61	7.99	12
Other Noncurrent Operating Assets	0.35	0.32	0.37	3.27	2.76	4.99	8.08	13
Total Liabilities & Shareholders' Equity	57	117	117	156	140	211	269	347
Total Liabilities	62	47	77	81	89	219	250	294
Total Current Liabilities	57	16	23	26	32	39	57	68
Accounts Payable	9.13	6.24	10	9.72	14	20	42	45
Accrued Expenses	2.33	6.13	11	15	16	17	14	17
Other Current Liabilities	46	4.08	2.20	1.65	1.18	1.69	1.84	6.98
Total Noncurrent Liabilities	4.67	31	54	56	57	180	193	225
Long-Term Debt	0.00	22	48	50	52	175	189	220
Other Noncurrent Operating Liabilities	4.67	8.32	5.53	5.70	5.00	4.83	4.36	5.88
Commitments & Contingencies	-	-	0.00	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-5.01	69	40	75	51	-8.19	18	53
Total Preferred & Common Equity	-5.01	69	40	75	51	-8.19	18	53
Total Common Equity	-5.01	69	40	75	51	-8.19	18	53
Common Stock	69	161	169	240	256	274	379	497
Retained Earnings	-68	-89	-127	-165	-206	-282	-360	-445
Treasury Stock	-6.47	-2.85	-2.85	-2.85	-2.85	-	-2.85	-2.85
Accumulated Other Comprehensive Income / (Loss)	0.08	0.45	0.69	2.87	3.66	2.72	1.96	3.29

This table presents Establishment Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	188	209	285	271	302	285	283
Total Current Assets	138	142	209	187	204	186	183
Cash & Equivalents	65	43	90	52	73	55	40
Accounts Receivable	31	41	51	55	51	60	67
Inventories, net	32	46	56	68	72	64	67
Prepaid Expenses	10	12	11	12	7.39	7.34	8.88
Plant, Property, & Equipment, net	39	57	66	73	79	80	79
Total Noncurrent Assets	10	10	10	11	19	19	20
Goodwill	0.47	0.47	0.47	0.47	0.47	0.47	0.47
Intangible Assets	4.63	4.37	4.23	5.71	9.52	10	9.78
Other Noncurrent Operating Assets	5.18	5.44	5.38	5.00	8.92	8.90	10
Total Liabilities & Shareholders' Equity	188	209	285	271	302	285	283
Total Liabilities	186	225	230	240	245	240	250
Total Current Liabilities	32	41	43	50	48	42	50
Accounts Payable	15	20	24	29	31	28	34
Accrued Expenses	17	20	17	19	15	12	14
Current Deferred Revenue	-	-	-	-	-	-	1.65
Other Current Liabilities	0.79	1.58	1.48	1.99	1.74	1.66	2.28
Total Noncurrent Liabilities	154	184	187	190	197	198	199
Long-Term Debt	148	179	182	185	192	194	194
Other Noncurrent Operating Liabilities	5.57	5.24	5.18	4.42	4.73	4.45	5.12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1.52	-16	55	30	57	45	33
Total Preferred & Common Equity	1.52	-16	55	30	57	45	33
Total Common Equity	1.52	-16	55	30	57	45	33
Common Stock	270	278	366	371	434	438	442
Retained Earnings	-268	-294	-310	-340	-376	-393	-410
Treasury Stock	-2.85	-	-2.85	-2.85	-2.85	-2.85	-2.85
Accumulated Other Comprehensive Income / (Loss)	2.60	2.31	1.81	1.95	2.08	3.12	3.23

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	76.49%	46.33%	-5.46%	49.61%	27.64%	2.13%	0.53%
EBITDA Growth	0.00%	61.31%	-292.38%	0.51%	-5.23%	-21.22%	-55.21%	-11.46%
EBIT Growth	0.00%	50.45%	-140.74%	1.50%	-7.03%	-37.36%	-52.40%	-1.66%
NOPAT Growth	0.00%	-19.42%	-29.66%	9.78%	9.94%	-57.75%	-63.97%	23.13%
Net Income Growth	0.00%	39.54%	-80.82%	0.08%	-7.92%	-82.82%	-4.38%	-7.76%
EPS Growth	0.00%	64.22%	-52.46%	12.37%	-5.52%	-79.07%	0.32%	2.28%
Operating Cash Flow Growth	0.00%	-5.99%	11.52%	58.28%	-120.08%	-89.47%	-69.68%	33.89%
Free Cash Flow Firm Growth	0.00%	0.00%	54.58%	70.21%	-173.51%	-199.16%	-40.58%	55.04%
Invested Capital Growth	0.00%	346.70%	27.91%	-19.62%	22.25%	105.00%	65.57%	9.11%
Revenue Q/Q Growth	0.00%	0.00%	9.61%	3.31%	7.06%	5.55%	-6.91%	8.46%
EBITDA Q/Q Growth	0.00%	0.00%	16.16%	-2.36%	-39.34%	8.58%	-18.05%	-32.70%
EBIT Q/Q Growth	0.00%	0.00%	13.81%	-1.77%	-30.05%	1.08%	-14.11%	-20.21%
NOPAT Q/Q Growth	0.00%	0.00%	11.99%	-14.86%	-5.67%	-10.58%	-15.97%	6.45%
Net Income Q/Q Growth	0.00%	0.00%	11.50%	-0.25%	-26.20%	0.83%	-9.76%	-19.81%
EPS Q/Q Growth	0.00%	0.00%	10.14%	3.55%	-29.32%	1.28%	-9.25%	-14.94%
Operating Cash Flow Q/Q Growth	0.00%	-1.01%	12.93%	37.36%	-67.99%	-13.75%	6.22%	-27.44%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	38.92%	-55.91%	-29.85%	5.75%	15.61%
Invested Capital Q/Q Growth	0.00%	0.00%	2.22%	-15.93%	1.97%	19.63%	2.13%	-1.83%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	51.04%	59.01%	61.25%	62.00%	67.42%	65.92%	64.78%	65.97%
EBITDA Margin	-44.40%	-9.73%	-26.10%	-27.47%	-19.32%	-18.35%	-27.88%	-30.92%
Operating Margin	-57.62%	-38.99%	-34.55%	-32.97%	-19.85%	-24.53%	-39.37%	-30.11%
EBIT Margin	-70.33%	-19.74%	-32.48%	-33.85%	-24.21%	-26.06%	-38.88%	-39.32%
Profit (Net Income) Margin	-100.62%	-34.47%	-42.59%	-45.02%	-32.47%	-46.51%	-47.53%	-50.95%
Tax Burden Percent	100.30%	101.03%	101.71%	100.27%	103.59%	103.28%	99.90%	99.96%
Interest Burden Percent	142.64%	172.80%	128.93%	132.65%	129.47%	172.85%	122.38%	129.65%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-143.44%	-48.52%	-43.25%	-39.33%	-36.98%	-33.97%	-20.03%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-122.11%	117.80%	110.28%	90.74%	-125.17%	-59.55%	-55.72%
Return on Net Nonoperating Assets (RNNOA)	0.00%	78.00%	-21.41%	-23.30%	-26.13%	-316.50%	-1,503.78%	-216.64%
Return on Equity (ROE)	696.13%	-65.45%	-69.94%	-66.54%	-65.46%	-353.48%	-1,537.75%	-236.67%
Cash Return on Invested Capital (CROIC)	0.00%	-183.18%	-73.02%	-21.49%	-59.35%	-105.83%	-83.35%	-28.74%
Operating Return on Assets (OROA)	-42.72%	-13.92%	-24.96%	-21.00%	-20.73%	-24.03%	-26.77%	-21.21%
Return on Assets (ROA)	-61.12%	-24.30%	-32.73%	-27.94%	-27.80%	-42.90%	-32.73%	-27.49%
Return on Common Equity (ROCE)	696.13%	-65.45%	-69.94%	-66.54%	-65.46%	-353.48%	-1,537.75%	-236.67%
Return on Equity Simple (ROE_SIMPLE)	696.13%	-30.36%	-96.30%	-50.85%	-81.08%	918.86%	-426.76%	-159.33%
Net Operating Profit after Tax (NOPAT)	-14	-17	-22	-20	-18	-28	-46	-35
NOPAT Margin	-40.33%	-27.29%	-24.18%	-23.08%	-13.89%	-17.17%	-27.56%	-21.08%
Net Nonoperating Expense Percent (NNEP)	-192.46%	-21.34%	-166.33%	-153.53%	-130.06%	88.20%	25.59%	35.70%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-16.60%	-21.98%	-12.83%
Cost of Revenue to Revenue	48.96%	40.99%	38.75%	38.00%	32.58%	34.08%	35.22%	34.03%
SG&A Expenses to Revenue	88.87%	77.27%	79.06%	78.68%	72.80%	77.91%	88.15%	84.21%
R&D to Revenue	19.79%	20.73%	16.74%	16.29%	14.46%	12.53%	16.00%	11.87%
Operating Expenses to Revenue	108.66%	98.00%	95.49%	94.97%	87.26%	90.45%	104.15%	96.08%
Earnings before Interest and Taxes (EBIT)	-24	-12	-29	-29	-31	-42	-64	-65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-15	-5.96	-23	-23	-24	-30	-46	-51
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	8.10	14.38	11.77	31.98	0.00	36.32	24.29
Price to Tangible Book Value (P/TBV)	0.00	8.59	15.96	12.54	35.34	0.00	67.20	32.08
Price to Revenue (P/Rev)	1.93	9.20	6.36	10.42	12.81	9.88	4.05	7.77
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	13.60	11.58	21.05	32.93	16.92	4.89	7.78
Enterprise Value to Revenue (EV/Rev)	1.62	8.71	6.48	10.01	12.80	10.56	4.95	8.55
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.32	1.22	0.66	1.02	-21.44	10.26	4.14
Long-Term Debt to Equity	0.00	0.32	1.22	0.66	1.02	-21.44	10.26	4.14
Financial Leverage	2.17	-0.64	-0.18	-0.21	-0.29	2.53	25.25	3.89
Leverage Ratio	-11.39	2.69	2.14	2.38	2.35	8.24	46.98	8.61
Compound Leverage Factor	-16.25	4.65	2.75	3.16	3.05	14.24	57.50	11.16
Debt to Total Capital	0.00%	24.31%	54.86%	39.93%	50.57%	104.89%	91.12%	80.53%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	24.31%	54.86%	39.93%	50.57%	104.89%	91.12%	80.53%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	75.69%	45.14%	60.07%	49.43%	-4.89%	8.88%	19.47%
Debt to EBITDA	0.00	-3.75	-2.06	-2.14	-2.12	-5.91	-4.10	-4.28
Net Debt to EBITDA	0.00	5.09	-0.45	1.49	0.06	-3.68	-3.23	-2.52
Long-Term Debt to EBITDA	0.00	-3.75	-2.06	-2.14	-2.12	-5.91	-4.10	-4.28
Debt to NOPAT	0.00	-1.34	-2.22	-2.55	-2.95	-6.32	-4.15	-6.28
Net Debt to NOPAT	0.00	1.81	-0.48	1.78	0.09	-3.93	-3.27	-3.69
Long-Term Debt to NOPAT	0.00	-1.34	-2.22	-2.55	-2.95	-6.32	-4.15	-6.28
Altman Z-Score	-2.20	7.14	3.61	5.77	9.78	3.24	0.08	1.30
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.69	6.05	4.12	5.11	3.55	3.85	3.06	3.56
Quick Ratio	0.42	4.27	2.60	4.00	2.44	2.61	1.52	2.28
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-72	-33	-9.71	-27	-79	-112	-50
Operating Cash Flow to CapEx	-3,548.28%	-1,957.54%	-476.83%	-516.30%	-521.24%	-159.16%	-381.21%	-686.16%
Free Cash Flow to Firm to Interest Expense	0.00	-8.14	-3.75	-1.04	-2.93	-2.58	-7.26	-2.41
Operating Cash Flow to Interest Expense	-3.07	-3.84	-3.45	-1.33	-3.04	-1.69	-5.75	-2.81
Operating Cash Flow Less CapEx to Interest Expense	-3.15	-4.04	-4.17	-1.59	-3.62	-2.76	-7.26	-3.22
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.70	0.77	0.62	0.86	0.92	0.69	0.54
Accounts Receivable Turnover	2.65	3.98	4.43	4.04	5.82	5.40	4.01	2.97
Inventory Turnover	1.29	1.32	1.30	1.24	1.60	1.70	1.00	0.71
Fixed Asset Turnover	2.57	4.63	6.11	5.19	7.27	4.64	2.57	2.14
Accounts Payable Turnover	1.86	3.26	4.18	3.20	3.41	3.19	1.89	1.31
Days Sales Outstanding (DSO)	137.96	91.70	82.35	90.29	62.76	67.56	90.99	123.03
Days Inventory Outstanding (DIO)	283.18	276.54	281.37	294.22	228.21	215.24	364.08	511.12
Days Payable Outstanding (DPO)	196.29	111.80	87.32	113.94	106.98	114.29	193.43	279.03
Cash Conversion Cycle (CCC)	224.85	256.44	276.40	270.57	183.99	168.51	261.64	355.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	-16	39	50	40	49	101	167	182
Invested Capital Turnover	-2.18	5.26	2.01	1.87	2.83	2.15	1.23	0.95
Increase / (Decrease) in Invested Capital	0.00	55	11	-9.83	8.96	52	66	15
Enterprise Value (EV)	56	533	580	848	1,621	1,707	817	1,419
Market Capitalization	67	563	570	882	1,622	1,598	668	1,290
Book Value per Share	($0.49)	$3.38	$1.92	$3.20	$2.11	($0.34)	$0.71	$1.90
Tangible Book Value per Share	($0.87)	$3.19	$1.73	$3.00	$1.91	($0.54)	$0.39	$1.44
Total Capital	-5.01	92	88	125	103	167	207	273
Total Debt	0.00	22	48	50	52	175	189	220
Total Long-Term Debt	0.00	22	48	50	52	175	189	220
Net Debt	-11	-30	10	-35	-1.51	109	149	129
Capital Expenditures (CapEx)	0.90	1.73	6.29	2.42	5.28	33	23	8.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-29	30	35	22	28	45	78	84
Debt-free Net Working Capital (DFNWC)	-18	83	73	106	81	111	118	175
Net Working Capital (NWC)	-18	83	73	106	81	111	118	175
Net Nonoperating Expense (NNE)	21	4.39	16	19	24	47	33	50
Net Nonoperating Obligations (NNO)	-11	-30	10	-35	-1.51	109	149	129
Total Depreciation and Amortization (D&A)	8.99	6.13	5.72	5.40	6.20	12	18	14
Debt-free, Cash-free Net Working Capital to Revenue	-83.38%	49.58%	39.01%	25.83%	22.08%	27.58%	47.06%	50.84%
Debt-free Net Working Capital to Revenue	-52.05%	135.58%	81.06%	125.65%	64.24%	68.61%	71.30%	105.26%
Net Working Capital to Revenue	-52.05%	135.58%	81.06%	125.65%	64.24%	68.61%	71.30%	105.26%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)
Adjusted Weighted Average Basic Shares Outstanding	10.23M	20.39M	23.33M	23.55M	23.97M	24.46M	25.60M	28.16M
Adjusted Diluted Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)
Adjusted Weighted Average Diluted Shares Outstanding	10.23M	20.39M	23.33M	23.55M	23.97M	24.46M	25.60M	28.16M
Adjusted Basic & Diluted Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	10.23M	17.35M	20.54M	23.32M	24.12M	24.42M	27.21M	28.85M
Normalized Net Operating Profit after Tax (NOPAT)	-14	-17	-22	-20	-18	-28	-46	-35
Normalized NOPAT Margin	-40.33%	-27.29%	-24.40%	-23.08%	-13.89%	-17.17%	-27.56%	-21.08%
Pre Tax Income Margin	-100.32%	-34.12%	-41.88%	-44.90%	-31.35%	-45.04%	-47.58%	-50.97%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.34	-1.37	-3.35	-3.06	-3.38	-1.37	-4.17	-3.13
NOPAT to Interest Expense	-1.34	-1.90	-2.49	-2.08	-1.94	-0.90	-2.96	-1.68
EBIT Less CapEx to Interest Expense	-2.43	-1.57	-4.07	-3.32	-3.97	-2.43	-5.68	-3.54
NOPAT Less CapEx to Interest Expense	-1.43	-2.09	-3.21	-2.34	-2.52	-1.97	-4.47	-2.09
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-22.41%	0.00%	-5.93%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	31.70%	24.07%	20.99%	17.90%	0.68%	-27.97%	-20.11%	-9.15%	4.47%	41.05%
EBITDA Growth	4.43%	29.52%	-91.62%	28.40%	-99.58%	-116.41%	-123.92%	-13.57%	59.83%	-87.85%
EBIT Growth	-14.15%	4.17%	-127.81%	12.68%	-78.25%	-81.80%	-59.75%	2.00%	55.97%	-57.13%
NOPAT Growth	-16.29%	-40.51%	-46.37%	-31.78%	-100.04%	-68.05%	-8.26%	31.86%	37.55%	15.58%
Net Income Growth	-26.77%	4.43%	-101.28%	54.87%	-57.31%	-51.47%	-35.67%	-2.60%	43.01%	-68.10%
EPS Growth	-24.59%	6.67%	-100.00%	57.24%	-47.37%	-46.43%	-20.83%	4.62%	47.32%	-47.56%
Operating Cash Flow Growth	-76.48%	-81.81%	-325.91%	-149.25%	-43.36%	41.87%	45.90%	49.88%	60.46%	-154.65%
Free Cash Flow Firm Growth	-547.37%	-292.51%	-376.43%	-149.47%	-116.33%	-34.08%	10.53%	48.90%	66.70%	65.35%
Invested Capital Growth	74.73%	105.00%	115.23%	109.25%	93.95%	65.57%	47.00%	25.56%	13.51%	9.11%
Revenue Q/Q Growth	-7.15%	14.56%	6.19%	4.38%	-20.71%	-18.04%	17.77%	18.70%	-8.82%	10.66%
EBITDA Q/Q Growth	6.67%	35.55%	57.44%	-152.92%	-160.15%	30.11%	51.31%	-28.28%	7.98%	-226.81%
EBIT Q/Q Growth	0.23%	25.24%	34.07%	-66.46%	-103.69%	23.75%	38.21%	-2.12%	8.50%	-172.14%
NOPAT Q/Q Growth	-1.07%	-25.13%	37.99%	-68.05%	-53.42%	-5.12%	60.05%	-5.77%	-40.61%	-42.10%
Net Income Q/Q Growth	49.85%	27.12%	11.95%	-40.22%	-74.82%	29.83%	21.13%	-6.04%	2.90%	-107.00%
EPS Q/Q Growth	50.00%	26.32%	14.29%	-35.42%	-72.31%	26.79%	29.27%	-6.90%	4.84%	-105.08%
Operating Cash Flow Q/Q Growth	-94.00%	36.23%	-47.07%	-36.99%	-11.58%	74.14%	-36.87%	-26.92%	11.96%	-66.51%
Free Cash Flow Firm Q/Q Growth	-25.77%	-40.19%	-14.69%	-23.36%	-9.07%	13.11%	23.47%	29.55%	28.92%	9.60%
Invested Capital Q/Q Growth	20.36%	19.63%	18.71%	22.42%	11.56%	2.13%	5.40%	4.56%	0.85%	-1.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.09%	64.28%	64.65%	62.32%	67.66%	65.23%	65.60%	65.59%	63.93%	68.50%
EBITDA Margin	-26.99%	-15.19%	-6.73%	-16.31%	-53.50%	-45.62%	-18.86%	-20.39%	-20.57%	-60.76%
Operating Margin	-27.50%	-30.04%	-17.54%	-28.24%	-54.64%	-70.07%	-23.77%	-21.18%	-32.66%	-41.94%
EBIT Margin	-36.96%	-24.12%	-15.97%	-25.47%	-65.43%	-60.88%	-31.94%	-27.48%	-27.58%	-67.82%
Profit (Net Income) Margin	-48.65%	-30.95%	-25.67%	-34.48%	-76.02%	-65.09%	-43.59%	-38.94%	-41.47%	-77.57%
Tax Burden Percent	103.35%	106.43%	107.47%	105.85%	102.34%	89.13%	102.78%	102.55%	103.15%	96.08%
Interest Burden Percent	127.38%	120.58%	149.54%	127.89%	113.53%	119.96%	132.79%	138.19%	145.79%	119.05%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-44.47%	-45.29%	-23.76%	-32.31%	-54.72%	-60.45%	-17.52%	-13.57%	-20.04%	-27.90%
ROIC Less NNEP Spread (ROIC-NNEP)	-76.80%	-53.37%	-32.43%	-42.10%	-68.19%	-64.38%	-25.38%	-22.78%	-25.27%	-43.34%
Return on Net Nonoperating Assets (RNNOA)	-84.69%	-134.95%	-146.31%	-86.89%	-460.15%	-1,625.54%	-158.16%	-52.66%	-114.41%	-168.51%
Return on Equity (ROE)	-129.16%	-180.24%	-170.07%	-119.20%	-514.87%	-1,685.99%	-175.68%	-66.23%	-134.44%	-196.41%
Cash Return on Invested Capital (CROIC)	-92.26%	-105.83%	-106.81%	-100.07%	-95.58%	-83.35%	-69.14%	-48.62%	-34.07%	-28.74%
Operating Return on Assets (OROA)	-33.70%	-22.25%	-15.45%	-18.60%	-50.67%	-41.92%	-19.47%	-14.58%	-15.26%	-36.59%
Return on Assets (ROA)	-44.37%	-28.55%	-24.84%	-25.18%	-58.87%	-44.82%	-26.57%	-20.67%	-22.95%	-41.85%
Return on Common Equity (ROCE)	-129.16%	-180.24%	-170.07%	-119.20%	-514.87%	-1,685.99%	-175.68%	-66.23%	-134.44%	-196.41%
Return on Equity Simple (ROE_SIMPLE)	-4,992.63%	0.00%	507.74%	-110.91%	-234.60%	0.00%	-145.42%	-184.81%	-215.86%	0.00%
Net Operating Profit after Tax (NOPAT)	-7.36	-9.21	-5.71	-9.60	-15	-15	-6.18	-6.54	-9.20	-13
NOPAT Margin	-19.25%	-21.03%	-12.28%	-19.77%	-38.24%	-49.05%	-16.64%	-14.83%	-22.86%	-29.36%
Net Nonoperating Expense Percent (NNEP)	32.33%	8.09%	8.68%	9.79%	13.47%	3.93%	7.86%	9.22%	5.23%	15.44%
Return On Investment Capital (ROIC_SIMPLE)	-	-5.51%	-	-	-	-7.47%	-	-	-	-4.79%
Cost of Revenue to Revenue	31.91%	35.72%	35.35%	37.68%	32.34%	34.78%	34.40%	34.41%	36.07%	31.50%
SG&A Expenses to Revenue	81.76%	79.53%	68.15%	76.25%	103.78%	116.86%	77.87%	74.33%	84.66%	98.89%
R&D to Revenue	13.83%	14.79%	14.04%	14.31%	18.51%	18.44%	11.50%	12.44%	11.93%	11.56%
Operating Expenses to Revenue	95.59%	94.32%	82.19%	90.55%	122.29%	135.30%	89.36%	86.77%	96.59%	110.44%
Earnings before Interest and Taxes (EBIT)	-14	-11	-7.43	-12	-25	-19	-12	-12	-11	-30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-10	-6.65	-3.13	-7.92	-21	-14	-7.01	-8.99	-8.28	-27
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	872.48	0.00	0.00	32.18	41.49	36.32	24.33	27.77	36.96	24.29
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	35.19	52.01	67.20	29.51	36.23	53.83	32.08
Price to Revenue (P/Rev)	8.65	9.88	9.74	9.97	7.13	4.05	8.89	8.26	7.90	7.77
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	16.69	16.92	14.94	12.67	8.54	4.89	8.54	7.54	7.34	7.78
Enterprise Value to Revenue (EV/Rev)	9.19	10.56	10.54	10.49	7.88	4.95	9.65	9.18	8.91	8.55
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	97.56	-21.44	-11.17	3.32	6.08	10.26	3.38	4.30	5.94	4.14
Long-Term Debt to Equity	97.56	-21.44	-11.17	3.32	6.08	10.26	3.38	4.30	5.94	4.14
Financial Leverage	1.10	2.53	4.51	2.06	6.75	25.25	6.23	2.31	4.53	3.89
Leverage Ratio	5.33	8.24	11.02	6.86	14.32	46.98	12.49	5.71	8.75	8.61
Compound Leverage Factor	6.79	9.93	16.48	8.77	16.25	56.36	16.59	7.89	12.76	10.25
Debt to Total Capital	98.99%	104.89%	109.83%	76.83%	85.87%	91.12%	77.15%	81.14%	85.59%	80.53%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	98.99%	104.89%	109.83%	76.83%	85.87%	91.12%	77.15%	81.14%	85.59%	80.53%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	1.01%	-4.89%	-9.83%	23.17%	14.13%	8.88%	22.85%	18.86%	14.41%	19.47%
Debt to EBITDA	-4.57	-5.91	-5.61	-6.33	-4.75	-4.10	-3.85	-3.80	-5.02	-4.28
Net Debt to EBITDA	-2.55	-3.68	-4.26	-3.20	-3.41	-3.23	-2.39	-2.73	-4.00	-2.52
Long-Term Debt to EBITDA	-4.57	-5.91	-5.61	-6.33	-4.75	-4.10	-3.85	-3.80	-5.02	-4.28
Debt to NOPAT	-5.90	-6.32	-6.04	-5.71	-4.72	-4.15	-4.18	-4.51	-5.20	-6.28
Net Debt to NOPAT	-3.30	-3.93	-4.59	-2.88	-3.39	-3.27	-2.59	-3.24	-4.14	-3.69
Long-Term Debt to NOPAT	-5.90	-6.32	-6.04	-5.71	-4.72	-4.15	-4.18	-4.51	-5.20	-6.28
Altman Z-Score	3.52	3.74	3.71	4.25	2.36	0.63	2.65	2.19	1.85	1.64
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.27	3.85	3.43	4.83	3.71	3.06	4.24	4.44	3.62	3.56
Quick Ratio	2.98	2.61	2.02	3.27	2.12	1.52	2.58	2.74	2.12	2.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-43	-61	-70	-86	-94	-82	-62	-44	-31	-28
Operating Cash Flow to CapEx	-516.33%	-138.14%	-487.44%	-314.76%	-495.77%	-222.50%	-234.93%	-925.70%	-763.07%	-3,352.02%
Free Cash Flow to Firm to Interest Expense	-11.20	-27.68	-18.60	-23.80	-25.55	-18.82	-14.27	-8.49	-5.89	-4.76
Operating Cash Flow to Interest Expense	-5.66	-6.37	-5.49	-7.80	-8.57	-1.88	-2.55	-2.73	-2.35	-3.49
Operating Cash Flow Less CapEx to Interest Expense	-6.76	-10.98	-6.61	-10.28	-10.29	-2.72	-3.63	-3.02	-2.65	-3.59
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.91	0.92	0.97	0.73	0.77	0.69	0.61	0.53	0.55	0.54
Accounts Receivable Turnover	5.48	5.40	4.80	4.25	4.13	4.01	3.39	2.72	2.51	2.97
Inventory Turnover	1.74	1.70	1.55	1.51	1.26	1.00	0.92	0.85	0.79	0.71
Fixed Asset Turnover	5.47	4.64	4.23	3.49	3.17	2.57	2.29	2.08	2.01	2.14
Accounts Payable Turnover	4.02	3.19	3.15	3.10	2.87	1.89	2.12	1.95	1.69	1.31
Days Sales Outstanding (DSO)	66.65	67.56	76.04	85.92	88.41	90.99	107.64	134.30	145.39	123.03
Days Inventory Outstanding (DIO)	210.18	215.24	234.84	241.69	288.91	364.08	397.13	428.17	461.11	511.12
Days Payable Outstanding (DPO)	90.76	114.29	116.06	117.62	127.21	193.43	171.81	187.41	216.21	279.03
Cash Conversion Cycle (CCC)	186.07	168.51	194.83	209.99	250.11	261.64	332.95	375.06	390.30	355.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	84	101	120	147	164	167	176	184	186	182
Invested Capital Turnover	2.31	2.15	1.94	1.63	1.43	1.23	1.05	0.92	0.88	0.95
Increase / (Decrease) in Invested Capital	36	52	64	77	79	66	56	37	22	15
Enterprise Value (EV)	1,408	1,707	1,790	1,858	1,398	817	1,504	1,389	1,364	1,419
Market Capitalization	1,325	1,598	1,654	1,766	1,265	668	1,385	1,250	1,209	1,290
Book Value per Share	$0.06	($0.34)	($0.66)	$2.13	$1.18	$0.71	$2.09	$1.64	$1.17	$1.90
Tangible Book Value per Share	($0.15)	($0.54)	($0.85)	$1.95	$0.94	$0.39	$1.73	$1.25	$0.80	$1.44
Total Capital	150	167	163	237	216	207	249	239	227	273
Total Debt	148	175	179	182	185	189	192	194	194	220
Total Long-Term Debt	148	175	179	182	185	189	192	194	194	220
Net Debt	83	109	136	92	133	149	119	139	155	129
Capital Expenditures (CapEx)	4.26	10	4.23	8.97	6.36	3.66	4.75	1.53	1.63	0.62
Debt-free, Cash-free Net Working Capital (DFCFNWC)	40	45	58	76	84	78	83	90	93	84
Debt-free Net Working Capital (DFNWC)	106	111	101	166	136	118	156	144	132	175
Net Working Capital (NWC)	106	111	101	166	136	118	156	144	132	175
Net Nonoperating Expense (NNE)	11	4.35	6.23	7.15	15	5.06	10	11	7.48	21
Net Nonoperating Obligations (NNO)	83	109	136	92	133	149	119	139	153	129
Total Depreciation and Amortization (D&A)	3.81	3.92	4.30	4.45	4.60	4.82	4.86	3.13	2.82	3.14
Debt-free, Cash-free Net Working Capital to Revenue	26.40%	27.58%	34.00%	42.66%	47.48%	47.06%	53.08%	59.23%	60.60%	50.84%
Debt-free Net Working Capital to Revenue	69.05%	68.61%	59.24%	93.57%	76.90%	71.30%	99.93%	95.30%	86.53%	105.26%
Net Working Capital to Revenue	69.05%	68.61%	59.24%	93.57%	76.90%	71.30%	99.93%	95.30%	86.53%	105.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.76)	($0.56)	($0.48)	($0.65)	($1.12)	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)
Adjusted Weighted Average Basic Shares Outstanding	24.51M	24.46M	24.68M	25.62M	26.03M	25.60M	27.79M	27.91M	28.25M	28.16M
Adjusted Diluted Earnings per Share	($0.76)	($0.56)	($0.48)	($0.65)	($1.12)	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)
Adjusted Weighted Average Diluted Shares Outstanding	24.51M	24.46M	24.68M	25.62M	26.03M	25.60M	27.79M	27.91M	28.25M	28.16M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.34M	24.42M	25.74M	25.78M	25.81M	27.21M	27.51M	27.94M	28.00M	28.85M
Normalized Net Operating Profit after Tax (NOPAT)	-7.36	-9.21	-5.71	-9.60	-15	-15	-6.18	-6.54	-9.20	-13
Normalized NOPAT Margin	-19.25%	-21.03%	-12.28%	-19.77%	-38.24%	-49.05%	-16.64%	-14.83%	-22.86%	-29.36%
Pre Tax Income Margin	-47.08%	-29.09%	-23.88%	-32.58%	-74.28%	-73.03%	-42.41%	-37.97%	-40.20%	-80.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.64	-4.80	-1.98	-3.42	-6.85	-4.43	-2.71	-2.34	-2.09	-5.07
NOPAT to Interest Expense	-1.90	-4.19	-1.52	-2.65	-4.00	-3.57	-1.41	-1.26	-1.73	-2.20
EBIT Less CapEx to Interest Expense	-4.74	-9.42	-3.10	-5.90	-8.58	-5.27	-3.79	-2.63	-2.40	-5.18
NOPAT Less CapEx to Interest Expense	-2.99	-8.80	-2.65	-5.13	-5.73	-4.41	-2.50	-1.56	-2.04	-2.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Establishment Labs' Financials

When does Establishment Labs's fiscal year end?

According to the most recent income statement we have on file, Establishment Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Establishment Labs' net income changed over the last 7 years?

Establishment Labs' net income appears to be on an upward trend, with a most recent value of -$84.60 million in 2024, rising from -$34.90 million in 2017. The previous period was -$78.50 million in 2023.

What is Establishment Labs's operating income?

Establishment Labs's total operating income in 2024 was -$49.99 million, based on the following breakdown:

Total Gross Profit: $109.53 million
Total Operating Expenses: $159.51 million

How has Establishment Labs revenue changed over the last 7 years?

Over the last 7 years, Establishment Labs' total revenue changed from $34.68 million in 2017 to $166.03 million in 2024, a change of 378.7%.

How much debt does Establishment Labs have?

Establishment Labs' total liabilities were at $293.74 million at the end of 2024, a 17.4% increase from 2023, and a 372.9% increase since 2017.

How much cash does Establishment Labs have?

In the past 7 years, Establishment Labs' cash and equivalents has ranged from $10.86 million in 2017 to $90.35 million in 2024, and is currently $90.35 million as of their latest financial filing in 2024.

How has Establishment Labs' book value per share changed over the last 7 years?

Over the last 7 years, Establishment Labs' book value per share changed from -0.49 in 2017 to 1.90 in 2024, a change of -487.0%.

Related Companies

This page (NASDAQ:ESTA) was last updated on 4/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Financials

Frequently Asked Questions About Establishment Labs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Financials

Annual Income Statements for Establishment Labs

Quarterly Income Statements for Establishment Labs

Annual Cash Flow Statements for Establishment Labs

Quarterly Cash Flow Statements for Establishment Labs

Annual Balance Sheets for Establishment Labs

Quarterly Balance Sheets for Establishment Labs

Annual Metrics and Ratios for Establishment Labs

Quarterly Metrics and Ratios for Establishment Labs

Frequently Asked Questions About Establishment Labs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools